Product Images Spironolactone

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Spironolactone NDC 70518-2385 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Remedy_Label - Remedy Label

Remedy_Label - Remedy Label

Spironolactone is a prescription medication that comes in a quantity of 100 HD2. It's only available with a prescription and is marked as RX only. Its NDC number is 70518-2385-00, and it was sourced from NDC number 68382-0660-01, manufactured by Zydus Pharm in Pennington, N.J 08534. It should be kept away from children and stored at a temperature of 20-26°C (63-77°F) with permitted excursions to 15-30°C (59-86°F) according to USP. Directions for use can be found in the package insert, and it was repackaged by RemedyRepack Inc., in Indiana, PA 15701, 724.466.8762.*

MM5 - Spironolactone 25mg 70518 2385 01

MM5 - Spironolactone 25mg 70518 2385 01

Spironolactone is a prescription medication that comes as one HD2; it is only available via prescription. It specifies the NDC number, manufacturing details, and medication safety instructions. The packaging should be kept out of children’s reach. The drug must be kept at room temperature (20-26°C or 63-77°F) with permissible temperature excursions of 15-30°C (59-86°F). The directions for use are provided in the package insert. The drug has been repackaged by RemedyRepack Inc, Indiana.*

Image - b9a028ee 5720 4b9e a625 f7130aafd084 01

Image - b9a028ee 5720 4b9e a625 f7130aafd084 01

Image - b9a028ee 5720 4b9e a625 f7130aafd084 02

Image - b9a028ee 5720 4b9e a625 f7130aafd084 02

This is a clinical trial study comparing the effects of Spironolactone (n= 822) with a Placebo (n= 841) in an unknown condition. The study reports a significant difference between the two groups with a log-rank p value of <0.001. The graph displays the results over a 42-month period.*

Image - b9a028ee 5720 4b9e a625 f7130aafd084 03

Image - b9a028ee 5720 4b9e a625 f7130aafd084 03

This appears to be a data table with various demographic and medical information related to heart failure patients, such as age, sex, race, LVEF (%), NYHA classification, diabetes status, creatinine and potassium levels, as well as medication usage (e.g. Digoxin, ACE inhibitors, and beta-blockers). There are also subgroups based on different criteria (e.g. age, race, heart failure type, etc.) and an indication of the number of patients in each subgroup. Finally, there is a graph showing the comparison between Spironolactone and Placebo in terms of treatment efficacy.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.